Tirzepatide / Glycine

(Ship Cold) Injection

16.6 mg / 7.5 mg / mL

Ready to prescribe?
Disclaimer: Images are for reference only; actual products may vary.

Product Overview

Tirzepatide / Glycine Injection Description1-4

Tirzepatide / Glycine Injection is a combination formulation containing tirzepatide and glycine. Tirzepatide functions as a dual incretin receptor agonist, targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, while glycine is an amino acid involved in protein synthesis.

Tirzepatide1-3

Tirzepatide is administered as a once-weekly subcutaneous injection and is used alongside diet and exercise to support glycemic control in adults with type 2 diabetes mellitus. It is also FDA approved for chronic weight management under the brand name Zepbound in specific populations. Tirzepatide is a novel dual agonist of GIP and GLP-1 receptors.

Glycine5-9

Glycine is an amino acid that can be produced endogenously by the body. It is a structural component of many proteins, including collagen, creatine, and purine nucleotides. In plasma, glycine represents approximately 11.5% of the total amino acid content. It has been studied in marathon runners for its anti-inflammatory and immunomodulatory properties, as well as its potential effects on physical performance and muscle development. Glycine has also been reported to play a role in the prevention of lung injury, gastric ulcers, and in conditions involving hemorrhagic and endotoxic shock.

Tirzepatide1-3

Tirzepatide exerts its effects through dual incretin receptor agonism, targeting both:

  1. GIP (Glucose-dependent Insulinotropic Polypeptide) Receptor:

  • Enhances insulin secretion
  • Reduces glucagon secretion
  • Promotes lipid metabolism and may contribute to weight loss
  1. GLP-1 (Glucagon-Like Peptide-1) Receptor:

  • Delays gastric emptying
  • Reduces appetite
  • Stimulates insulin release in a glucose-dependent manner
  • Inhibits glucagon release during hyperglycemia

 

Glycine5-9

Glycine exerts its anti-inflammatory effects by inhibiting cytokine synthesis, reducing serum transaminase levels and works on decreasing calcium levels inside cells. The cytokines that glycine inhibits are TNF-a, interleukin-6, interleukin-1b. It also increases the levels of anti-inflammatory cytokines including interleukin-10 found in macrophages and leucocytes.

Adverse Reactions 1-4,8

Most adverse reactions are gastrointestinal in nature and dose-dependent:

  • Gastrointestinal: Nausea, vomiting, diarrhea, constipation, dyspepsia, decreased appetite, abdominal pain
  • Headache, dizziness, and injection site reactions

Contraindications & Precautions 1-4

Contraindications:

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of serious hypersensitivity to tirzepatide or any component of the formulation
  • Nonketotic hyperglycinemia (NKH) or other genetic disorders preventing absorption of amino acids.

Precautions:

  • Pancreatitis risk: Monitor patients for signs/symptoms (serious abdominal pain)
  • Severe gastrointestinal disease: Use with caution; only if benefit outweighs potential risk.
  • Acute kidney injury: Especially in those with dehydration, vomiting, or diarrhea.
  • Diabetic retinopathy: Rapid improvement in glucose may worsen retinopathy.
  • Use with insulin or secretagogues: Dose adjustment may be necessary to reduce hypoglycemia risk.

Pregnancy & Lactation:
- No adequate data; use only if benefit outweighs potential risk.
 Discontinue at least 1 month prior to a planned pregnancy due to long half-life

Store refrigerated at 36°F to 46°F (2°C – 8°C). Discard within 28 days of puncture or according to the beyond-use date. Do not freeze. Keep out of reach of children.

  1. Clinical Pharmacology powered by Elsevier (ClinicalKey) – Tirzepatide Monograph. https://www.clinicalkey.com

  2. FDA Prescribing Information – Mounjaro® (tirzepatide): https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf

  3. Jastreboff AM, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” NEJM. 2022; 387(3):205–216. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

  4. Drucker DJ. “Mechanisms of Action and Therapeutic Application of GLP-1 and GIP.” Cell Metabolism. 2018. https://doi.org/10.1016/j.cmet.2018.06.015
  5. Ramos-Jiménez A, Hernández-Torres RP, Hernández-Ontiveros DA, Ortiz-Ortiz M, López-Fregoso RJ, Martínez-Sanz JM, Rodríguez-Uribe G, Hernández-Lepe MA. An Update of the Promise of Glycine Supplementation for Enhancing Physical Performance and Recovery. Sports (Basel). 2024 Sep 25;12(10):265.
  6. Aguayo-Cerón KA, Sánchez-Muñoz F, Gutierrez-Rojas RA, Acevedo-Villavicencio LN, Flores-Zarate AV, Huang F, Giacoman-Martinez A, Villafaña S, Romero-Nava R. Glycine: The Smallest Anti-Inflammatory Micronutrient. Int J Mol Sci. 2023 Jul 8;24(14):11236.
  7. Razak MA, Begum PS, Viswanath B, Rajagopal S. Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review. Oxid Med Cell Longev. 2017;2017:1716701.
  8. Glycine-adverse reaction overview. https://ontosight.ai/glossary/term/glycine-adverse-reaction-overview–67a164126c3593987a56a572. Accessed June 25, 2025
  9. Glycine – Professional Monograph; NatMed Pro ; 2025 ; https://naturalmedicines.therapeuticresearch.com/Data/ProMonographs/Glycine

WPPL operates as a 503A compounding pharmacy and prepares individualized prescription medications pursuant to provider direction. Compounded preparations are not reviewed, tested, or approved by the FDA.

This listing also includes commercially manufactured products for convenience; these items are not compounded by our pharmacy and are sold as provided by their manufacturers. Actual products in stock at time of dispensing may vary due to supply chain variability. Any statements regarding non-compounded products are manufacturer-supplied, have not been evaluated by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease. WPPL does not verify or endorse any therapeutic claims made by manufacturers. Please refer to original labeling for complete product information.

EXPLORE MORE

Related Medications

Licensed to ship across the U.S.

Your orders arrive promptly and privately, delivered directly to your door.

Providers: Let’s Partner for Better Patient Care

If you are a physician, clinic, or practice seeking a dependable Compounding Pharmacy partner, WP Pharma Labs is here to help. With dedicated account setup, streamlined ordering and responsive service, we support your therapeutic goals with specialized compounds designed for your patients.

To check product availability, check on the status of an existing order, request refills:
orders@wppharmalabs.com

New providers setup / update an existing account:
newaccounts@wppharmalabs.com